close provid prelim adj ep guidanc
bracket consensu view estim also
re-affirmed ep guidanc reflect stronger
expect oper perform tax benefit off-set
million one-tim expens relat initi combat opioid
epidem note adj ep exclud billion impair
charg relat european rexal busi conjunct
announc acquisit medic specialti distributor msd
million detail well elus multi-year strateg growth
initi detail limit includ variou undefin
oper restructur strateg reinvest lower
ep midpoint guid msd acquisit off-set
detail medic specialti distributor msd msd nation
distributor medsurg suppli biomed equip
therapi msd revenu grew dd
time sale new mountain capit custom base includ
acquisit bolster specialti infus busi recent
acquir intrafus houston-bas provid manag servic
physician offic infus center financi detail
disclos transact expect close modestli
accret ep embed guid risk includ shift
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
deliv pharmaceut medic suppli
healthcar inform technolog custom
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
share may rise view guidanc respect encourag
refer oper upsid also bode well lead
drug distributor
said limit detail provid today press releas continu await
import commentari regard msd financi details/rational lt announc
strateg growth initi confer call tomorrow morn et
key question tomorrow call includ underli dynam updat
branded/gener price opportun specialti rexall/europ impair charg
sale
ebit
predominantli acut distribut market share recent move non-acut
 byram transact via ambulatori surgic center asc idn altern site
includ privat label own-brand product repres ldd revenu follow
acquisit hyh ip busi expect strateg goal total revenu
sale
sale
ebit
serv us hospit custom mix gener either larg surgeri center acut
hospit less way smaller buyer physician practic
includ cardin privat label sale post-acut servic
sale
sale
ebit
market leader altern site defin custom excl acut hospit care
divest acut care med-surg distribut busi
privat label brand
sale
sale
ebit
note sale last fiscal year
custom pcp specialist group practic ambulatori surgeri center excl
hospit pharmaci
us physician practic us revenu segment
market share address market
expect make greater invest devic move forward higher margin vs high
includ pharmaceut medic sale physician-administ vaccin
compani mention price
